Status Reports:

=== 1. Liju for relations branch - add ppt===

Collected horizontal relations between OBI branches also top down. Defined these and also used same format as relation-ontology. Mostly inter branch relations with domain and range. Also have some data type annotation properties, no conclusion yet on if this should be retained. Reviewed relationship ontology, concluded that was insufficient for OBI and started therefore defining OBI relations. All are now in the OBI OWL file (also see ppt). 

Discussion

RS:why is biomaterial an input. This should be an input for a biomaterial protocol application, is not an input in itself. 

BS:there is now a tracker on OBOfoundry.org/row, check pending relations from OBO- list of new relations, including the OBO list. Some are output and input relations, could be general input - could be anything, also more specific investigation, assay, biomaterial etc. Hope that OBI doesn't need any specific relations. Hope that OBI can use the same small set, needs to be tested. OWL allows you to add relations easily, and in case of Snomed are > 100 variants where the domain and range are minor variants. Needs to be constrained. Also defs need to be provided. BS states that we should be careful not to add too many relations: the DL version of SnoMed has 108 relations currently. BB says that text definitions for classes and properties are just there to help the humans: restrictions should also be present in OWL, in a manner that matches the text definition as much as possible.

LF:Trying to find upper level relations, if we don't find we will propose to Chris Mungall. We needed to record the original relations requested from OBI as well.

BB:In creating constraints needed to provide logical definition, it gets very specific and that limits use. E.g. has_input - in context of an lc column.

BS:Problems about expressivity of OWL, and requirement for human and computer readable. Stating domain and range is not enough. In the paper we suggest the all sum constraint. Allows reasoning. 

BB:some things in OWL cannot be done in Protege, or are hard to do consistently. Could get close to what BS is asking for. Text def is for humans, agree, but OWL is expecting that this be provided as restrictions etc. 

BS:why do we need 2 input relations data and biomaterial. Could be simpler. Agreement on this. 

BB:Proliferation on long relations is an RDF thing, not an OWL thing. Can avoid this proliferation if we define functions instead.

LF:suggests that relationship names be done more consistently e.g. is_adjacent_to. 

RS:what's the difference between has_input and utilizes? 

AL:suggest that reagents and instruments are unchanged.

BS:all we need is has_participant? 

BB:if we define the reagent role then we can do this. Role, process and function branch need to cooperate.

LF:is_proxy_for now points from continuant-continuant as domain and range. The text definition of the term and the DL are not consistent. Needs addressing. 

BS:doesn't seem an all sum relation. SO the c1 will appear in contexts where doesn't appear as a proxy. 

AR:this is the instance level relationship.

BS:Propose a solution, OWL allows instance level, every row all sum is on class level and presupposes instance level relns. We need these instance level relns. (Alan can only have these in OWL). Is OBI like GO and have class level relns in some version, or will it be a mixture of class and instance relns. AR:class relns are shorthand for axioms on instances. 
AR and others: we would like to have no class-level relationships. 
BS:go has established node-edges where edges are reln
AR:these relationships are shorthand, and they can be used as such
GF: In OWL, you can define class-level relations, but it's not a good idea (brings us towards OWL Full). BS: There is a simple OBI statement "PA_Chromium_release has_participant radioactive_chromium" doesn't sound like a relation between instances, but instead between "any old" chromium etc. What it should say it "Every instance of chromium_release_assay has, on the instance level, some instance of radioactive_chromium." that means two relations for everything. CS: You're talking syntactic sugar: saying the same things, but want to have "your" way of saying it be the correct one. AR: The disagreement is that he thinks it's syntactic sugar and BS doesn't. BS actually agrees that it's syntactic sugar, but only if we really know what we're doing: i.e. we need to be VERY sure that, if we decide to only do instance-level relations, that is what we should be sure that we're always doing. General agreement. AR: you can think of these as extra axioms. We should audit all relations to make sure that they're all instance-level reactions. E.g. have axiom on chromium_release_assay that it must always have a reagent, and then make the appropriate notes in the relations used to express that. BS: there is no "problem" in OBO in that you can only use class-level relations. HP made a list of action items for this.
BB:you can see that some definitions are ambiguous. Liju agrees.


<b>AA:Relations for OBI to be checked vs. OBI tracker and submitted if new. Examples and definitions are needed, less relationships will be easier to use and maintain. BS suggests use of all sum as well. E.g. utilizes_reagent replaced by utilizes. Need to be clear if we are defining instance level relations only.</b>

===Tina for Data Transformation branch  - add ppt, add link to protege file===

Lots of stats terms, no statistical ontology. We need this. Philippe is concerned that we have function creep. 
CC:what's the difference between a math function and a transformation?
JM:issues with the higher classes. These are work in progress. These are not nec good high level classes. 
PRS:we had case where we had a transformation, want to know how granular we could be. To level of function and parameter, and which log? 
AR says that some classes should be under linear and non-linear transformation, whereas now they are siblings. There's also the fact that mathematical functions aren't necessarily PAs (parent of Data Transformation). They are functions/methods which might be better elsewhere. E.g. functionX has_role linear transformation. BS: OBI shouldn't be "doing mathematics", as it isn't central to OBI's mission. We should find '''somebody''' who can take care of the central maths that we need. Also, don't use the same noun at the end of a long list of children: shows that should make a parent class of that group. Also, ensure all classes are singular! Also, we need to be very careful about child/parent relationships: a Transformation is NOT a Transformation Method: it is a transformation! LF: Methods aren't PA, they're plans/protocols. Also, she says errors are not PAs, they might be qualities instead. JF says developers have agreed that errors should be measurements.
Normalization method is a role. Could use it for many other things, will get multiple inheritance. Use in a normalization instead. 
BS:Don't like the idea that OBI goes into maths, we need to find a group of maths people to do this. Can understand stats methods being in scope. Same as units ontology. Small point, usually a bad sign if using same noun at the end of child terms, use subclasses. Every term in an ontology has to be a singular noun. Feeling that method is being used as a general header, not good. A transformation is not a transformation method.
LF:Agree with Barry, adjectives shouldn't be class names. I don't know what a method is, - seems like a protocol. Needs to be moved out of this branch. Error is a quality. AR:calc of type 1 error, calc of type 2 error.
JF:Error is a measurement
BB:SW ontology [[http://bioontology.org/projects/ontologies/SoftwareOntology/]] is under dev and this overlaps. Want to see this overlap with OBI. DT need to be reconciled with this. 


DS:we should have a way to id classes that are not yet correctly placed. We add a new properties to represent 'temporary placement' and things that 'should be out of scope' but no one else is doing. 
BS:we should also send this to Chris
CS:addressing Alan's comment that normalization is a role. Most people regard it as a data transformation.
AR:Issue is not that normalization can't be well define, arc-sin norm vs arc din function. Need to organise this so that we don't have multiple inheritance. Could classify the uses. If arc sine is defined elsewhere, how do we deal with arc sine transformation. 
BS:need a classification that's compatible with the method
AR:The classification of applications, would be normalization, plotting, and arc sine norm would be a defined term, then we need to know where normalization and plotting live. 
HP:These are processes.
AR:We want to all of these terms here, and if you make as defined classes, they would end up here. I could show how that would work.

<b>AA: address naming issues, be more clear on mathematical function vs. method, rename for being in protocol application, or move to plan. Identify areas of overlap with the SW ontology from Daniel Rubin, which is under development but not yet in use. Correct typo in logical. Look for a mathematical ontology. AR will build an inferred version to investigate avoiding multiple inheritance.</b>

<b>AA: AR will break out all the meta data properties into a separate OWL file so Bill can use these for BIRNLEX instead of his own. Agreed</b>

===Allyson for Instrument branch===

121 terms, mostly flow cytometry, and MO terms, added most complete first. Some PSI terms will go direct to OWL file. Also looked at instrument use cases. File in SVN. General issues, which dimension should instruments - electric, mechanic, analytical, preparative, passive vs active. Hard to decide which to assert. OBI platform under BFO collection should be in the instrument OWL file. Why? We think all instruments are an object aggregate - back  to the granularity case. Depends what granularity we want? Do we want platform as an object aggregate or as object. 
BB:depends on need, do we need to address the pieces, or not? If we need these then instrument has to be an object aggregate.
AR:I would say use object, practically object aggregate is hard to use
AL:platform belongs with object, use relations to talk about interesting parts. We discussed cardinal_part_instrument is a placeholder for part of. By using reln we don't need to use object aggregate. Plan is to remove cardinal_part_of. Under that reasoning platform belongs  instrument branch. 
RS:is defined as reagents, sw and instrument. Notion of platform is it is a collection that together form the platform. 
AL:all these things could be done with relations anyway, reagents etc. 
AR:what's an example of use? check what you mean 'platform instance' cell some parts can be swapped and is still the platform? Def is not clear, grab all instruments, sw and reagents,  for a protocol application does that = a platform?
AL:good questions
AR:instruments have these definitions e.g. a sequencer. Is there a good case?
RS:we need it and is positioned OK and def works
BS:granularity issues in OBI will cause problems. For platform and instruments are distinct. There are objects, parts and collections in all branches. Need all these levels. Collections sounding odd is aesthetic only. Looks more natural within a branch.
CS:agree with RS, like definition of platform. Is more than instrument
AR:two platform types, get a platform from a vendor, or all stuff in x's lab is a platform. 
CS:all stuff in a lab is not a platform. Is the lab. We could add that as a concept. 
AR:clarify in notes and definition
BB:we will use this to describe instances e.g. image devices. We need to describe parts of images of confocal microscope. Lots of parts and these are important. Can't see how will be used to describe instruments. Need to have relns for each type of platforms.
AR:Class defs for Affy are simple. 
BB:not simple in optical system.
AR:is this term intended to mean a turnkey platform, or something that can build up
RS:we need to define instruments and when group with reagents is a platform. Will have may o f these. 
GF:is there a collection of instruments that is not a platform? Some platforms are computational
PRS:platform has an application, this is missing
CC:True that no artefact can be a biomaterial - as current hierarchy suggests
AR:this is a problem as biomaterial hasn't resolved this. E.g. plasmids is unresolved.
BB:I don't understand why we need artefact objects
HP:didn't we decide on phone call to remove artefact.
BB:get rid of artefact
AR:what's a device?  This should be reomved and added as a synonym for instrument
Discussion on classification of instrument handler as function or as a class and what is the best way to classify
CS:instrument names reflect functions
AL:and these are overlapping, how do we proceed? Assertion?
RS:cells can be described on function vs structure, chose structure as is stable and knowledge of this changes less. 

BS: the granularity issue: the OBI domain encompasses several granularities, and we may deal with multiple granularities in the same annotation project, so there will be problems. We know the appropriate granularity for dealing with instruments. There are some things that are truly object aggregates. There are objects, parts of objects, and object aggregates in everything we do. It sounds odd but should be that way. Most people using obi will not be using the whole thing. AR: there should be a distinction between what you can buy as a single item, as opposed to something that takes up multiple rooms and has to be put up specially. CS: we don't call the latter a platform, but instead a laboratory, and therefore wouldn't be needed. We need two types of platform: one that you're not going to take apart, and another that allows you to adjust the parts. however, some things you build yourself is only because it isn't a mature technology yet - it would become a platform when it's mature. AR: should only be called a platform when it's mature. BB: some platforms are only software. PA: the difference between platform and group of instruments is that a platform is a group that has been put together for a specific purpose. Plate reader is an instrument that is used in the context of many different platforms. Included in the definition is some link to either Plan or PA.

BS: Having many children is fine, just make sure you have no redundancy. Then after they're in, see if there's any way to bundle them. AR has seen people put defined classes into owl:THing but this isn't very good. You could make "bogus" classes under instrument. Not good answers - don't really want ugly pseudo classes. AR: someone will find it useful to have aliquid handler term. RS: The instrument's function may change, but its structure might not, so we definitely shouldn't use their function.

AR and AL summary of artefact_object discussion: The children of artefact_object could just as easily be moved up to be disjoint siblings of biomaterial, rather than having artefact_object be disjoint. Domesticated animals are shaped by human craft, as are transgenic mice. Yet these were also considered to be Biomaterials. FWIW, even the Biomaterials class was put under question - is Biomaterial a role? There was also the question of what inferential power the superclass would have - if you know something is an artefact_object then how can use that piece of information for profit? Further information from BB and others can be found in the email thread http://sourceforge.net/mailarchive/forum.php?thread_name=CB4A902B-6FDD-4BA5-B99A-679212DC0E27%40DrexelMed.edu&forum_name=obi-devel

Conclusion: we decide that platform doesn't move to instrument and stays in current place, but can be included in Instrument OWL file. Done by AR svn version 100/. Some of the other classes are also redundant, i.e. remove device and move up instrument and labware.


<b>AA: improve the definition of the platform, address reagent part to deal with computational platform where no typical reagents are used and to include being put together for a purpose. Should not include vendor. Will now be included in OWL file to aid editing - AR will do that. Also need assn with ProtocolApplication what is the platform used for. Remove artefact - we can see no reason why this stays with current definition. Remove device and make as a synonym for instrument</b>

===Jennifer for Role Branch add ppt===

200 terms, reviewing them, file on Google docs (add link). Not yet in OWL. 

===Jennifer for digital entities===

Includes goal and conclusions, measurements. File types, XML file - format standard - wants input on that. 

BS:This is the point where talk to Ivo , he has been working on an ontology of format standards as SW tool standards. 
BB:agree, should decide what we need and try to talk to then, not clear when things would be ready. 
AR:under narrative object Tim Clark, and Elizabeth Wu (swan people) have interest here

<b>AA:Look into overlap with Swan project and the SW ontology</b>


===Presentation from Jennifer on the Clinical Trial Ontology progress===

Clinical Trial Ontology. Now ontology for clinical investigation OCI. Has clinical/regulatory implications.
Interacting with other groups, HL7, Infomis, Bridge, Epoch. These are mostly data modellers. Scope, any legal terms in clinical trials defined by FDA etc. There is a min info in the consort statement. Clinical research, administrative terms.

LF:clinical trials def seems only to be done in humans, not true. Also animal drugs in vet. science. 
JF:correct, FDA also takes pre-clinical data, not animal drugs, is pre human testing, SEND group. Being brought into OBI as well. Similar structure will work. e.g. subject. Focus on translational research and alignment of terms. Collected term lists, e.g CDISC->text file. STDM, file sharing description, similar one for send. Terms been organised, categorised in OBI h'archy and providing defs. Christian Cocos here to help with placement. Had a workshop to determine where CTO should go. Thinks OCI terms should be in OBI. OCI sees OBI as a master ontology. Questions on if OCI is a superset or a subset of OBI. Some other cttes need these terms e.g. Nutrigenomics. 

BB:Colorado group on Clinical Models included? JF will check
AL:should this be a MIBBI checklist? 
SS:already there
AR:http://esw.w3.org/topic/HCLSIG/Drug_Safety_and_Efficacy
RS:want to be clear that when we had this workshop, was mixed responses. Some people though there was value, some were skeptical. This will be controversial project
BS:Two gps doing different things, and did not interact easily,
RS:some people thought there would be no added value. Onus on us is therefore to show added value. If we do that we will win over people. 

The scope of CIO would encompass: the legal terms and minimal information (CONSORT) for clinical trials, clinical research, and administrative terms. Would like to align terms from other efforts with OBI. In OCI, all of the subjects are human. Other groups are doing non-human (e.g pre-clinical or non-clinical efforts). These efforts should be considered - we want them all to use "subject", for example, and mean the same thing. The ontology for clinical trials is in production by the UK cancergrid project. Their aim is to develop a useable ontology by 4Q07 that can be deposited in OBO. JF applauds the effort and hopes that they can all work together. As good as all these efforts all, there is definitely a feeling of "sporting competitiveness" too. 

OCI will focus for now on translational research, e.g. clinical research as opposed to trials. The collected terms are from the CDISC glossary (35-page pdf file), STDM (standard tabulated data model: how you would share your files with the FDA), UTSW, MUSC, and RCT. They've organized them all and removed duplicates, and loosely categorized them within the OBI hierarchy. They're now in the process of refining definitions, and have shared terms with the roles and digital entities branches.

OCI would be part of OBI, but there would be a document which contains all of OCI for the benefit of that community. This matches as a 4th-tier owl file as discussed yesterday, or does it? Would OCI be a subset of OBI, or a superset of OBI? CC will show us their OWL file during the next talk. Plan a workshop next year to bring together all efforts for discussions. They have a google group, OCInv@googlegroups.com. CONSORT is already in MIBBI.

===Presentation from Christian Cocos===
OBI has been imported into OCI. An OCI namespace will be used.
AR:potential migration issues in the future.
BS:OCI should be a view and should live within OCI. But namespace will be part of URL and this needs to be worked out
AR:is political not technical
CC:file has Simona Carini's terms, roles
PRS: we need transparency, as there is a lot of overlap, and I need to know how you are handling things. 
RS:We need to give you protocol applications etc. How do we best do this
AL:may depend on how much will be in OBI
JF:want to move all to OBI, can't imagine it's  aproblem that we don't have OCI in name space. This file, Christian started work on it without knowing about OBI. He looked at the branch structure, role, function etc had questions. All terms in the files need to be aligned with OBI and Christian needs to agree that this is sensible. 
CC:Issue wit OBI is not stable, no reason for us to import it, until is stable. Won't see many terms here. 
JF:CTO is different to OBI and hasn't be re-factored. Want one structure though.
RS:OCI working group could be an OBI community
BB:that was what I understood
SS:I do sympathise many issues with clinical ctty, there will be more buy-in with OBI. 
JF:that's the idea with OCI, we need to think about how to make OCI sep for publication reasons etc while still being part of OBI.



<b>AA:Summary of email thread is useful to be added to the wiki for all long threads</b>

===Philippe for Plan Branch===

Protocols, Study Design, Algorithm. We left protocol out as we had an overlap with ProtAppl. Decided to focus on study design. Collected terms, have some bias for clinical trials. Problems: all qualifiers concatenated 'study' - they indicate the result of a process, can also be considered as a set of processes. Processes have been identified and submitted to ProtocolApplication. We have terms and there are pointers to a pubmed id for examples. These terms are represented in the literature, if we decompose terms then we need to rebuild them for users. How to do that? Views? Most of terms are suffixed with designs - would prefer to keep these for many terms. 
RS:some terms are homonyms for difft things and this allows us to keep things straight
PRS:2 sets of terms, those that design expts e.g. stats and other set from terminologies related to biology. Need to reconcile both camps, stats terms may not have much use for biologists
CS:Those 2 are natural divisions of types of studies. Are there overlaps? Could have these as 2 branches?
PRS:Don't know. Need to explore that. There will be some specific relations that show up.
CS:But that is OK, they will have a common parent, iotype and stattype studies, will be distinguished by relations that you described
PRS:design of experiment is key element of the ontology to demonstrate the plan of the study. Need to know stat methods chosen for study, controls etc. Then there was a slide in the scope, I am not an expert, hard to model accurately.
BS:want to see more of the definitions. 
AR:Could be that there was an alternative term for two different ontology definitions, two senses of the same term. Found a couple of e.g. where a single term is used strictly and loosely. OK to have those
PRS:these two views are almost orthogonal, when driving data acquisition, what would we ask? 2x2 factorial design, not terms used by biologists. 
AR:there will be a clear use for the stat terms, and e.g. markup for bioconductor. We need these here. 
PRS:also submitted terms to other branches e.g factors into roles.
AR:has_control, type relations are needed
JF:problematic. If you have something in the study has_role placebo no need for design. No need to say, could infer that.
AR:maybe there are sub roles of control then?
JF:positive and negative for e.g. 
JF:twin study, interventional etc - is a combinatorial explosion
PRS:should be a way to say in design what were the controls. Need to find a way what you are controlling for. 
AL:we need to decide across obi, will there be a define class and infer?
AR:sent to group an analysis of a way of factoring these, manage the inhertance by using relns and letting the classifier handle it
BS:study and trial are mixed, is there a tree version?
PRS:Trish and Alan helped with that.
BS:are they arist. definitions? Goal should be doing this by inference using classifier as Alan suggested. Good thing to make a list, need easy targets to build a classification. Subjects good place to start 'offspring' vs 'parent'. Not a criterion for classification that gets to study, better classification of subject types will help
What to do, in general, about adding terms quickly? Many of the terms are suffixed with "parent" words, like _design and _study. BS doesn't like this sort of naming, however some of these suffixes are very important. What should be done? Well, just ensure that the suffix clarifies and is not redundant. JF: If you have a design that included something that was part of the trial with the role of "placebo", then you don't need "placebo_design" as a term, as this could be inferred. You don't need to explicitly say it twice. AL: this is the same problem as we face with the Instrument branch and terms like "liquid_handler". BS: In the definitions, sometimes you use the word "trial" and somewhere you use "study", and this needs to be cleaned up. Offspring study and Parent study are the same study with two different subjects. Therefore instead, what there should be is a good classification of the subject time, and then just link a study to a particular subject type. 
JF:we have that in CEBS
BS:want to see a classification of study types
AR sends his classification:
1) Are "subjects" measured at a series of times? (alternative:  There is a single measurement per subject)
2) Are "subjects" manipulated as part of the study? (alternative:  subjects are only observed)
3) Are "subjects" pre-classified as members of a set of groups?  (alternative: groups are discovered, post analysis)
4) Are "subjects" always individuals? (alternative: they be populations)
BS:could be adding new terms daily, need to find a principled way to do that.

JF:people classify things differently e.g. in ArrayExpress
AR:handle that by the browser.
BS:People worry about the bottomless pit as they find hard to place things. OBI will assist  people in creating checklists as they can check on deposition
AR:Open world assumption, therefore need extra info.
AL:Agree, practicalities though. What level do we do to. Where do we start the defined classes and finish?
BB:MPO is being re-factored with PATO, we would look to do something similar. We need a means to infer these types, and we also need the flexibility.  Minimal lists are important, but also makes sure that communities get elements from here and that they mean the same thing.
AR:Concerned about selecting the primary axis. Easier to do all defined definitions, and have only inferred is-a.
AL:if in instrument, add all relns, infer all is-a and select one that we require. Hard to find the right axis.
AL:suggests we pick a branch, deal with the relations e.g. instrument as an experiment.
BS:qualities of instrumentation belong in OBI.
BS: Identify the 7 or 9 or 3 essential features that every study should have, e.g. subjects. Pick one that is central, and then assert a single-inheritance hierarchy on that basis. All other features should be put into their own single-inheritance hierarchy. Then use the reasoner to generate all of the appropriate associations and multiple inheritance on the fly. We may end up with the bottomless pit problem, though. We have to find a way of making it clear it isn't a bottomless pit. It should be clear that there is a principled way for finding places for these terms. JF: different people structure these things with different "primary" classifications. AR: use "faceted" browsers. Classic example is travel destination, where you may want to browse by either sport, or location, or family friendliness. Each of these facets are different relations whose target is these other single hierarchies BS mentioned. AL: Where do we start the defined classes, and where do we end the "standard" classes? AR: Should avoid "hardness" as long as possible. Could have no asserted isA until the last step, and the infer all isA's, and see how it plays out, and *then* choose the primary asserted hierarchy. A lot of this work will be integral to the Function Branch work, which BB will cover shortly.

PA: PATO will deal with biological qualities, but not non-biological ones like randomized or control, or qualities of instrumentation like "switched on". Such terms should go in OBI, at least for now.

<b>AA. Work on subjects to help classify experiments e.g. offspring, study, twin, see Alan's list above etc. Check definitions are aristot.</b>

===Susanna for BioMaterial Branch===

See report sent for BioMaterial branch. Issues:
Dealing with common terms e.g. lot?
Dealing with external resources, poss present in multiple
Some terms were material, not biomaterial, need to change top class to Material?
Where to put genetic info - allele/obi etc

BB:In BIRNLEX we get NCBI taxonomy, we get the taxon as an annotation property, and use e.g. for mouse, rat. Provided a framework that maps to datasets annotated already. We need to map to that somehow. If was in OBI wouldn't need it in BIRNLEX.
72/315 terms were actually relevant to the biomaterial branch. There is a dispatcher sheet that is now on google docs. Have started refining definitions, adding examples, and making terms compliant to naming conventions (the latter is still to be done). Most of the information is in an excel spreadsheet. They don't know what to do about "quasi" material terms like lot number and serial number. What to do if a term is present in more than one external resource? How do we point at multiple sources of terms? Where should we put in genetic information like allele, diplotype. They are also thinking that they should probably also extend biomaterial to other types of material.

*Note added from Karen Eilbeck 11 Jul 2007: genotype, diplotype, and allele now in SO latest version.

First division was between experimental and natural biomaterials, but after a little time it was clear this wasn't the right line to draw: for example, where to put transgenic organism? Also, just binned things like allele and haplotype into a single class, even though they don't really know where to put them. Many of the genotype specification are already in PATO. And currently, things like dominant and recessive are not yet in PATO. And, even though we can get PATO into OBI really easily, ontologies like SO are harder to fit in, as their structure doesn't mesh with OBI yet, so we can't just import them directly. AR: if we can get it in promptly, we do it. If we can't, then we put a specialist ontology term directly within OBI. Also, for links out to other ontologies, we don't use an OBI term ID but the ID from the other ontology. Note that this does NOT mean that we import the entirety of the hierarchy above or below that particular external term, just that (for now) we need to represent that particular, single, term.

BS:OBI can't take over the world. Need to have these in PATO or to SO

AR:we'll base logical definitions to these, we need to import them, will be incoherent. Propose as we need such terms, add to OBI, can use them and are OK for local use, and create logical definitions and will then create a use case for OBI and then migrate to some external ontology. OR use external URI, but won't use all of OBI will use part.

BS:Propose keep the PATO and SO people informed

AR:SO talks about patterns not substances. 

CS:observation, experimental vs. natural, I have a sense that a transgenic is an experimental

HP:what about Ecotype or Canton S strain, these were natural and are now lab strains

JF:we had a model organism, and subject type and subject nature. Wild vs. lab.
AL:These are roles.
AR:adding history then to object type is bad
BS:Cooked meat is still the same continuant. Agree cases can deal with role. Not a clear moment in time when transformation occurs. 
AR:we need a guideline about how we add history to objects
BB:for mice, people look at pedigrees, and people want to do that. Goal is to have what we need. In keeping with OBO foundry, worry about GeneticInformationContent, we should add these as qualities and tell PATO. 
BB:there are a lot of terms that could go into OBI 
SS:what about all the other terms that we have identified as being out of scope of PATO. 
AR:suggest have these in OBI in the short term.
BB:should be in the correct place in OBI, e.g. quality. If you get a set of terms e.g. cell  type and half are there and other half not, then can't import to get the half you need. 
SS: True for any other branch then, will be a lot of work to do. In the latest call we had a consensus to focus on what we needed rather than out of scope terms.
BS:organism is in other ontologies. 
CS:we need classes to refer from and this is not a problem even if this is in an another ontology.
AR:we can take the ids from taxonomy for e.g.
BB:in BIRNLEX if there is an external anything need to decide based on your ontology where you need to put it, but maintain links to external ontology. Organism is an is-a. 
SS:possibility to have additional qualities in PATO for experimental terms. OBI can hold these qualities.
BS:Allele is in the sequence ontology. 
BB:whole_mount doesn't like this placement in biomaterial, is a technical preparation process that is imaging. 
AR:if is a defined class can be an is-a that's an output of some protocol application. 
BS:not just the output of the whole mount process, if you drop it it's no longer a whole mount organism. Is therefore a role after the process, need both forward and backward history
CS:once is a whole mount is a different kind of entity, agree that whole_mount is more like lysate
AR:yes
AR: Population and cohort's current placement is not their final location. Diplotype is a quality of a sequence.
AR: If you have a defined class for whole_mount, you can say whole_mount organism is exactly those organisms that are the output of PA_XYZ. BS: A whole_mount organism is an organism playing the role of whole_mount. CS: But once it goes through PA XYZ, it is an entirely new entity. This entity can take on other roles, such as garbage, but it is a new entity. BS: It is simple to do what I propose, as you just have to add a phrase about the role to the defined class definition (necessary & sufficient statement). BB: What we're trying to do is figure out where to put in that a biomaterial has been experimentally manipulated. BS: We need to have this role as, for example, you need the role to properly classify patients. You can't just say patients are people who have registered, as that would fit with people who once registered but are no longer true patients (e.g. they went home). RS: whole_mount is irreversible - once you are a whole_mount, you can't go back. For this reason, you should not use roles, as roles are for states that can be easily changed to one thing and then back again and then on to another thing. BS: You can have an organ section that does not play the role of the specimen (e.g. your dinner of part of a liver), therefore specimen is a role. As such, you need to define whole_mount with such role restrictions. CS: whole_mount cannot be a role, but in its definition I'm ok with it indicating that it plays the role / always plays the role of specimen. BB: to reinforce this, you could rename ExperimentalBiomaterial to BiomaterialSpecimen. JF: thinks biomaterial is actually a role, e.g. a fly before it is in an experiment is not a biomaterial. AL: A fly is always a biomaterial, irrespective of whether or not it is in an experiment.
JF:biomaterial is a role. We need to sep fly before it was in experiment. 
general disagreement with this statement.

BB:these are all materials
RS:there are biomaterial entities and they are possibly also playing roles
BS:a lysate is something you create experimentally not just inside my body. Everying in OBI should be an artefact of the experiment. 


<b>AA Issues then: how to classify terms in OBI, how to deal with the terms that are likely in external ontologies and hold in OBI temporarily, how to import external ontologies, whether to import all of external ontologies or some of an external ontologies. Bill and Alan to write up an example for discussion on importing external ontologies. Barry will ask PATO and SO to speak to each other about both having Ploidy </b>



===Bill for Function Branch [[Image:OBI-FunctionBranchSummary-forOBImtg-july2007-BB-001.pptâ€Ž]]===
Definition for function branch is problematic, is BFO derived. Need to bring in some more BFO classes and create children in Bill's HPLC molecular separation function example. - e.g. Compound Sample. Some problems here, e.g. Compound Solution and Compound Samples are not distinct. Very complex, needs to refer to biomaterials, instruments, parts of instruments. Tried to keep the classes needed to be simple and not v. granular. 

BS:not clear how separate function and role here. Test of function, possible that it is not functioning, easy to see that a sperm can have a function that doesn't function. As in primary purpose. When we say an algorithm has a function this is not relevant to the BFO form of function. Functions need realizations. The thing that has the function must take place in causal processes. Algorithm doesn't do that

BB:So only the executable.
BS:not all things have functions, heart has a function, the pumping of the heart doesn't have a function

BB:apart from algorithm, all are functions. 
BS:assessment(assay) and algorithm are problems. Occurrents don't have functions.
BB:Purpose would be better
BS:Purpose is intentionally not in BFO.
CS:different issue with algorithm, think of as a plan. If algorithm has function, all plans have functions. Plan is a kind of realizable entity. 
BB:All physical entities can have functions. Need to know what function means for us. 
RS:some of the things in HPLC diagram are related t o function and some could be in the def
BB:this is the point, trying to be clear about the relations needed
RS:I think you could describe the function of separation without describing the function
GF:not clear on function and role, and inherent. Doesn't help me. All look like functions, and a role is a relation between an obi entity and function. Context is important. 
BB:started with simplest view, simple text, find that if you want a def that connects objects you need specific relations. 
AL:for molecular separate function will you point just to instrument, which will have a cardinal part
BB:yes.
RS:not that these other parts of instrument are not relevant, is an indirect connection
BB:not certain that this will be the case. Don't know how from BFO to implement functions in an OWL file
LF:like the slide - so system parts play roles to complement the system function.

Meant to provide a BFO-based definition of function for investigational artefacts, including instruments, reagents, and assays. They analyzed the BFO definition of the related realizable dependent continuants function, disposition and role, and defined how they are going to work with closely-related branches like role. They have a few examples/use-cases for function on the wiki page. They use as a primary example how to create the function of an HPLC system (high pressure liquid chromatography). He then used a well-written slide to show what minumum relations would be required to get the function correct for HPLC.

<b>AA:In Bill's example function and role are mixed. BFO may need to look at whether function and role are appropriate. Assay and algorithm do not have functions according to Barry. Investigate.</b>

Christian:function is intrinsic, role is context dependent. 
BB:disagree. Functions are they inherent - heart to pump blood inherent only under some conditions. Slides to be added about functional relations. 

BS: How are you distiguishing functions and roles from this particular example slide? BB: I don't think there is a clear distinction - it's not clear that function and role are distinct. BS: This is a BFO responsibility. BB: Well, the separation process is distinct. BS: whenever you have function, you should describe the process that is the functioning. A crucial feature of function is that you can have a function without realizing it (this statement applies equally to role). One test of a function is to see if it is possible to still be itself when it isn't functioning. When we say an algorithm has a function, we're not using it in the BFO sense. Functions have to involve realizations as a possibility, which means the thing that has the function has to be such that it can engage in causal processes. BB: I don't think that will work. BS: A laptop has a function, a heart has a function. The pumping of your heart is the exercise of the functioning of your heart. You cannot realize the pumping because the pumping is itself a realization. I think there are assays, but assays themselves do not have functions in the BFO sense. (Assessment is also a problem for him). Generally speaking, occurrents do not have functions. (And then BS had to leave the workshop.)

CS: I think of algorithm as a plan. AR: But you can't have a plan that has a function as they are both realizable entities. But still, perhaps algorithm is a plan, but you couldn't give it a function.

BB's slides include various cardinal parts of instrument, which CS describes as not necessary for the "molecular separation function", just required for the HPLC instruments.

BB: Should look at CC's proposal to use Systems Theory to provide a framework for defining function. It would be a relatively superficial application of ST.

CC says that in order to specify functions you don't need context, but for roles you do need context. BB: Functions imply some primacy, so perhaps each thing only has a single function?

CC: drafted by BS last year to write the "RO 2" paper. Some paradigm examples include:
# kidney UNDERGOES excretion process. There is disagreement on this term, as a kidney does not undergo that process. Blood undergoes filtration, and urine undergoes creation process. In the sense CC has written it is "participates", or has_function.
# excretion process HAS_PARTICIPANT nephron
# excretion function IMPLEMENTED_BY kidney/kidney IMPLEMENTS excretion function. 
# kidney HAS_OUTPUT urine / urine OUTPUT_OF kidney. RS: We've defined processes as having inputs and outputs, and CC has a continuant with inputs and outputs. Urine is the output of a process, in the same way as chocolate bar is the output of the chocolate production process, whereas others would say it is the output of the factory.

BB: we want your help implementing functions and relations in OWL. RS: There is confusion in this example, as many organs don't have outputs. CC: Actually, I think all organs have outputs.

BB: As people in other branches hit functions (especially the Instrument branch) please go to the function wiki page and add the example to that page.

===Alan for Protocol Application Branch===

Using ontology not slides. 

Plan and protocol application not clear. Using input and output of protocolappl as participants, input roles and are named in plan. is-proxy-for - in measuring you have label often for example. 
RS:tumour grading is not an assay, has an interpretive process not included there. 
RS:On data transformation were 3 categories - pool, some kind of partition, transformation where net no of molecules doesn't change e.g exposure, or change temp
CS:disagrees. Doesn't see a reagent as in input per se. Think about a node edge diagram. Reflect material of interest not other reagents. 
AR:need to consider in branch. Other cases are important e.g. planning of the protocol reagents are important there. Could distinguish roles further. Maybe one is a specimen and one not. 
Some redefining of terms was done.
Some fixes identified.
Discuss Assay, need to add more terms, want to do some modelling via relations. Chromium release that came from Kevin.

The group started out trying to figure out what relations should be used. HP: the clinical_diagnosis definition should not have "determination", but instead "assessment", as you may not always get your diagnosis right. RS: Doesn't think tumor grading is an assay, as there is an interpretive step that's not being captured. AR: The output is not material, but instead is information. RS: In tumor grading, the input and output are both data. Perhaps should be moved to Data transformation.

CS: Could delineate material combinations based on whether or not it is a pooling of samples. RS: You should structure according to pooling, partitioning, and transformation. BB: Perhaps shouldn't use transformation in material_transformation - should use a word that more precisely meets the definition.
 
<b>AA clinical_diagnosis definition is bad clean up, along with other definitions. Syntax needs clean up.</b>
<b>add new curation_status: 
# placeholder until can be accepted in the correct ontology (e.g. until your suggestions get submitted into PATO)
# placeholder just so we won't forget about them (e.g. collected_relations)
# a third that I can't remember right now</b>

Discussion of Agenda for Weds.

<b>Given agenda items, we decided to focus on the common problems, need to know what these are.</b>








Notes by Helen Parkinson and Allyson Lister


[[category:Workshops]]
[[category: 2007]]
